Daniel Ting/LinkedIn
Oct 9, 2025, 06:55
All You Need to Know About Generative AI in Medicine from Daniel Ting and Colleagues
Joao Monteiro, Chief Editor at Nature Medicine, shared on LinkedIn:
”All you need to know about generative AI in medicine in a single Review!
Daniel Ting and colleagues survey what has happened (and what has not) in medicine since the release of ChatGPT and the large-language models boom.
- Technical evolution of generative artificial intelligence
- Clinical applications of generative artificial intelligence
- Evaluation and quality assurance
- Future opportunities”
Read the full article in Nature Medicine.
Article: Generative artificial intelligence in medicine
Authors: Zhen Ling Teo, Arun James Thirunavukarasu, Kabilan Elangovan, Haoran Cheng, Prasanth Moova, Brian Soetikno, Christopher Nielsen, Andreas Pollreisz, Darren Shu Jeng Ting, Robert J. T. Morris, Nigam H. Shah, Curtis P. Langlotz, Daniel Ting

Stay updated on all scientific advances with Hemostasis Today.
Andreas Pollreisz
Arun James Thirunavukarasu
Brian Soetikno
Christopher Nielsen
Curtis P. Langlotz
Daniel Ting
Darren Shu Jeng Ting
Generative AI
Haoran Cheng
Health
Hematology
Hemostasis
Hemostasis Today
Kabilan Elangovan
Medicine
Nature Medicine
Nigam H. Shah
Prasanth Moova
Robert J. T. Morris
thrombosis
Zhen Ling Teo
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy